<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.peertechzpublications.org/assets/xsl/oaitohtml.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
										<responseDate>2026-05-12T05:44:12Z</responseDate>
										<request verb="GetRecord" metadataPrefix="oai_dc" identifier="oai:www.peertechzpublications.org:10.17352/2640-7876.000016">https://www.peertechzpublications.org/oai-pmh</request><GetRecord><record>
								<header>
									<identifier>oai:www.peertechzpublications.org:10.17352/2640-7876.000016</identifier>
									<datestamp>2019-09-20</datestamp>
									<setSpec>PTZ.GJRD:VOL4</setSpec>
								</header>
								<metadata>
									<oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
										<dc:title>
										A Case Report of a Malignant Triton Tumor of the Left Retroperitoneum in a Young Female Without Neurofi bromatosis
										</dc:title><dc:creator>Dayton Grogan BS</dc:creator><dc:creator> Vamsi Reddy BS</dc:creator><dc:creator> Earl Dane Jones</dc:creator><dc:creator>Cargill H Alleyne</dc:creator><dc:description>&lt;p&gt;Malignant peripheral nerve sheath tumors (MPNST) are malignant cancers with origins found within peripheral nerves of various body regions-most commonly involving the buttocks, thighs, brachial plexus and para-spinal region [1]. While MPNSTs account for only 5%-10% of all soft tissue sarcomas, there exist MPNST variations that occur with greater rarity [2]. Specifi cally, Malignant Triton Tumors (MTT) are a subset of MPNST with rhabdomyoblastic differentiation and account for only 5% of all MPNST cases [3]. MTTs were fi rst described by Mason in 1932 and found to occur in patients with Neurofi bromatosis type 1 (NF-1) in slightly more than 50% of cases. This is because sMTTs are believed to originate from Schwann cells of peripheral nerves or within existing neurofi bromas [3,4]. Diagnosis of MTT is confi rmed by immunohistochemical screening for desmin, vimentin, actin, myoglobulin, and S-100 protein.&lt;/p&gt;</dc:description>
										<dc:publisher>Global Journal of Rare Diseases - Peertechz Publications</dc:publisher>
										<dc:date>2019-09-20</dc:date>
										<dc:type>Case Report</dc:type>
										<dc:identifier>https://doi.org/10.17352/2640-7876.000016</dc:identifier>
										<dc:language>en</dc:language>
										<dc:rights>Copyright © Dayton Grogan BS et al.</dc:rights>
									</oai_dc:dc>
								</metadata>
							</record></GetRecord>
						</OAI-PMH>
